US-based pharmaceutical giant McKesson is setting up a service center in Vilnius.
© DELFI / Domantas Pipas

According to information from the Center of Registers, McKesson Business Services Lithuania was registered on Wednesday with an authorized share capital of 5 million euros and Ildiko By as its CEO.

The new company is wholly owned by McKesson's European unit, Germany-registered McKesson Europe Holdings.

McKesson, one of the largest pharmaceutical businesses in the US, ranked 13th among the world's largest companies by 2018 revenue, next to Apple, Glencore, Samsung and others.

McKesson posted 208.4 billion US dollars in revenue for the 2017-2018 financial year, up 5 percent from 198.5 billion dollars a year earlier.

BNS

Changes in option taxation prepared

The Parliament of the Republic of Lithuania approved an amendment to the Law on Personal Income Tax...

Finance Minister: we need to finish started work

Lithuania's Finance Minister Vilius Sapoka has so far declined to say if he plans to continue...

US experts checking Lithuania's egg producer

US experts have on Monday started inspecting Lithuania's egg producer Baltic Egg Production , part of...

Lithuania plans to set aside funds for deep radioactive waste repository

Lithuania plans to start accumulating funds to build a deep repository for spent radioactive waste...

Available office space in Vilnius is set to double in coming years

In recent years the average vacancy rate for offices in Vilnius has been about 3 percent, one of...